Lo
LogicBio (closed)
Cambridge MAFounded 2014
Private CapbiotechAcquiredRare Disease
Platform: GeneRide
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| LOG-8406 | LOG-8406 | Phase 3 | 2 | SOS1 | CF | ||
| Sovazasiran | LOG-821 | Phase 1/2 | 1 | SOS1 | HCCSchizophrenia |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)